![](https://canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaVVFIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--184616e1a127fc40783985e1396513382a6ff6eb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/Logos.png)
IntrepidiaBio
IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer and other diseases through drugs that alter the body’s first line of defense, innate immunity.
Partner
Nina KjellsonInvestment
Series A
IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer and other diseases through drugs that alter the body’s first line of defense, innate immunity.
Series A